BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 30251384)

  • 1. Benzyl sulforaphane is superior to sulforaphane in inhibiting the Akt/MAPK and activating the Nrf2/ARE signalling pathways in HepG2 cells.
    Ren J; Yuan L; Wang Y; Chen G; Hu K
    J Pharm Pharmacol; 2018 Dec; 70(12):1643-1653. PubMed ID: 30251384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary supplementation with sulforaphane ameliorates skin aging through activation of the Keap1-Nrf2 pathway.
    Petkovic M; Leal EC; Alves I; Bose C; Palade PT; Singh P; Awasthi S; Børsheim E; Dalgaard LT; Singh SP; Carvalho E
    J Nutr Biochem; 2021 Dec; 98():108817. PubMed ID: 34271100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of ROS, Nrf2, and autophagy in cadmium-carcinogenesis and its prevention by sulforaphane.
    Wang Y; Mandal AK; Son YO; Pratheeshkumar P; Wise JTF; Wang L; Zhang Z; Shi X; Chen Z
    Toxicol Appl Pharmacol; 2018 Aug; 353():23-30. PubMed ID: 29885333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulforaphane protects Microcystin-LR-induced toxicity through activation of the Nrf2-mediated defensive response.
    Gan N; Mi L; Sun X; Dai G; Chung FL; Song L
    Toxicol Appl Pharmacol; 2010 Sep; 247(2):129-37. PubMed ID: 20600217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane regulates apoptosis- and proliferation‑related signaling pathways and synergizes with cisplatin to suppress human ovarian cancer.
    Kan SF; Wang J; Sun GX
    Int J Mol Med; 2018 Nov; 42(5):2447-2458. PubMed ID: 30226534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactational transfer of sulforaphane-N-acetylcysteine in vivo and in human breast milk.
    Shore R; Behlen J; McBee D; Prayaga K; Haugen F; Craig L; Shields M; Mustapha T; Harvey N; Johnson N
    Toxicol Appl Pharmacol; 2024 Jan; 482():116796. PubMed ID: 38145809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileukemic activity of sulforaphane in primary blasts from patients affected by myelo- and lympho-proliferative disorders and in hypoxic conditions.
    Fimognari C; Turrini E; Sestili P; Calcabrini C; Carulli G; Fontanelli G; Rousseau M; Cantelli-Forti G; Hrelia P
    PLoS One; 2014; 9(7):e101991. PubMed ID: 25019218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring sulforaphane as neurotherapeutic: targeting Nrf2-Keap & Nf-Kb pathway crosstalk in ASD.
    Shah A; Varma M; Bhandari R
    Metab Brain Dis; 2024 Mar; 39(3):373-385. PubMed ID: 37249861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane.
    Bauman JE; Zang Y; Sen M; Li C; Wang L; Egner PA; Fahey JW; Normolle DP; Grandis JR; Kensler TW; Johnson DE
    Cancer Prev Res (Phila); 2016 Jul; 9(7):547-57. PubMed ID: 27339168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulforaphane Ameliorate Cadmium-Induced Blood-Thymus Barrier Disruption by Targeting the PI3K/AKT/FOXO1 Axis.
    Tong YX; Zhu SY; Wang ZY; Zhao YX; Saleem MAU; Malh KK; Li XN; Li JL
    J Agric Food Chem; 2024 Jun; 72(23):13382-13392. PubMed ID: 38814005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of 4-hydroxynonenal in chemopreventive activities of sulforaphane.
    Sharma R; Sharma A; Chaudhary P; Sahu M; Jaiswal S; Awasthi S; Awasthi YC
    Free Radic Biol Med; 2012 Jun 1-15; 52(11-12):2177-85. PubMed ID: 22579574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review.
    Sailo BL; Liu L; Chauhan S; Girisa S; Hegde M; Liang L; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulforaphane Inhibits IL-1β-Induced IL-6 by Suppressing ROS Production, AP-1, and STAT3 in Colorectal Cancer HT-29 Cells.
    Sah DK; Arjunan A; Park SY; Lee B; Jung YD
    Antioxidants (Basel); 2024 Mar; 13(4):. PubMed ID: 38671854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive activity of sulforaphane.
    Jiang X; Liu Y; Ma L; Ji R; Qu Y; Xin Y; Lv G
    Drug Des Devel Ther; 2018; 12():2905-2913. PubMed ID: 30254420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphane Improves Lipid Metabolism by Enhancing Mitochondrial Function and Biogenesis In Vivo and In Vitro.
    Lei P; Tian S; Teng C; Huang L; Liu X; Wang J; Zhang Y; Li B; Shan Y
    Mol Nutr Food Res; 2019 Feb; 63(4):e1800795. PubMed ID: 30578708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphane.
    Isaacson RH; Beier JI; Khoo NK; Freeman BA; Freyberg Z; Arteel GE
    J Nutr Biochem; 2020 Jul; 81():108399. PubMed ID: 32388251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer properties of sulforaphane: current insights at the molecular level.
    Asif Ali M; Khan N; Kaleem N; Ahmad W; Alharethi SH; Alharbi B; Alhassan HH; Al-Enazi MM; Razis AFA; Modu B; Calina D; Sharifi-Rad J
    Front Oncol; 2023; 13():1168321. PubMed ID: 37397365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulforaphane Ameliorates the Intestinal Injury in Necrotizing Enterocolitis by Regulating the PI3K/Akt/GSK-3
    Bao ZK; Mi YH; Xiong XY; Wang XH
    Can J Gastroenterol Hepatol; 2022; 2022():6529842. PubMed ID: 35600210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and Future of Non-Small Cell Lung Cancer Metastasis.
    Zhu T; Bao X; Chen M; Lin R; Zhuyan J; Zhen T; Xing K; Zhou W; Zhu S
    Front Oncol; 2020; 10():585284. PubMed ID: 33262947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Glucosinolates: A Sulphur Glucoside Family of Mustard Anti-Tumour and Antimicrobial Phytochemicals of Potential Therapeutic Application.
    Melrose J
    Biomedicines; 2019 Aug; 7(3):. PubMed ID: 31430999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.